ALN-PCS02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALN-PCS02, covering 2012-10-12 to 2012-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C) [Phase 1]